Difference between revisions of "Team:BGU ISRAEL/Design"

 
(13 intermediate revisions by 2 users not shown)
Line 41: Line 41:
 
                             <ul class="dropdown-menu submenubgu">
 
                             <ul class="dropdown-menu submenubgu">
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Parts#Overview">Overview</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Parts#Overview">Overview</a></li>
−
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Basic_Part">Basic Part</a></li>
+
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Basic_Part">Basic Parts</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/ImprovedParts">Improved Parts</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/ImprovedParts">Improved Parts</a></li>
 
                             </ul>
 
                             </ul>
Line 48: Line 48:
 
                             <ul class="dropdown-menu submenubgu">
 
                             <ul class="dropdown-menu submenubgu">
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Integrated_Practices">Integrated Practices</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Integrated_Practices">Integrated Practices</a></li>
−
                                <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Engagement">Public Engagement</a></li>
 
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/PlasticArt">Plastic Art</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/PlasticArt">Plastic Art</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/EthicsAndSafety">Ethics & Safety</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/EthicsAndSafety">Ethics & Safety</a></li>
Line 57: Line 56:
 
                             <ul class="dropdown-menu submenubgu">
 
                             <ul class="dropdown-menu submenubgu">
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Entrepreneurship">Entrepreneurship</a></li>
 
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Entrepreneurship">Entrepreneurship</a></li>
−
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Model">Model</a></li>
+
                                 <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Measurements">Measurements</a></li>
 +
                                <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Proof">Proof Of Concept</a></li>
 +
                                <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Demonstrate">Demonstrate</a></li>
 +
                                <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/HP/Silver">HP - Silver</a></li>
 +
                                <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/HP/Gold">HP - Gold</a></li>
 +
                                <li><a href="https://2016.igem.org/Team:BGU_ISRAEL/Engagement">Engagements</a></li>
 
                             </ul>
 
                             </ul>
 
                         </li>
 
                         </li>
Line 64: Line 68:
 
             </div>
 
             </div>
 
         </nav>
 
         </nav>
−
 
  
 
         <div class="container-fluid">
 
         <div class="container-fluid">
Line 80: Line 83:
 
                     <p class="bigAssHeader">Rational Mutagenesis</p>
 
                     <p class="bigAssHeader">Rational Mutagenesis</p>
 
                     <div class="DesignText">
 
                     <div class="DesignText">
−
                        <p>
+
<p>
−
                            <b>Cells, Plasmids and Enzymes</b>
+
−
                        </p>
+
−
                        <p>
+
−
                            <i>E. coli</i> strain MG1655 was used for cloning of the LC-Cutinase genes into the pACYC vector backbone. <i>E. coli</i> strain BL21 was used for protein expression.
+
−
                            The wild type LC-Cutinase gene with the pelB leader sequence was obtained from the <a href='https://2012.igem.org/Team:UC_Davis'>UC-Davis 2012 iGEM team</a> (<a href='http://partsregistry.org/wiki/index.php?title=Part:BBa_K936013'>Part:BBa_K936013</a>) and was amplified using primers containing restriction sites matching the pACYC backbone.
+
−
                            The amplified gene was restricted with XhoI and BglII and ligated into pACYC using the T4 ligase enzyme.
+
−
                        </p>
+
−
                        <p>
+
−
                            After cloning activity test were performed using a pNP-Butyrate assay and PET degradation assays.
+
−
                        </p>
+
−
                        <img src="https://static.igem.org/mediawiki/2016/2/2b/Cuti_designBGU.png" alt="" class="designPics">
+
−
                        <p>
+
 
                             <b>Protein Mutagenesis</b>
 
                             <b>Protein Mutagenesis</b>
 
                         </p>
 
                         </p>
 
                         <p>
 
                         <p>
−
                             Based on the LC-Cutinase structure, a rational mutagenesis approach was chosen for our project.
+
                             Based on the structure of LC-Cutinase, we decided to use a rational mutagenesis approach, in which we introduce various mutations to the enzyme's sequence. The mutations were designed using the PROSS (Protein Repair One Stop Shop) algorithm, developed by the Fleishman Lab from the Weizmann Institute (Goldenzweig et al 2016).
−
                            In this approach, various mutations were designed using the PROSS (Protein Repair One Stop Shop) algorithm that was developed by the Fleishman lab from the Weizmann Institute (Goldenzweig et al 2016).  
+
                          </p>
 +
                          <p>
 +
                        The algorithm uses the following steps in selecting the mutations:
 +
                          </p>
 +
                          <p>
 
                             A sequence alignment was generated between the target wild-type sequence and other homologous sequences, from which several mutations were chosen.
 
                             A sequence alignment was generated between the target wild-type sequence and other homologous sequences, from which several mutations were chosen.
 
                         </p>
 
                         </p>
Line 106: Line 101:
 
                         <p>
 
                         <p>
 
                             By computing the effects of each mutation separately,  
 
                             By computing the effects of each mutation separately,  
−
                             rather than in combination with others, design choices which included several ‘Potentially Stabilizing’ mutations (‘Potentially Stabilizing’ are mutations with ΔΔG<sub>calc</sub> ≤ -0.45 Rosetta energy units(R.e.u.)),  
+
                             rather than in combination with others, design choices which included several ‘Potentially Stabilizing’ mutations (‘Potentially Stabilizing’ are mutations with ΔΔG<sub>calc</sub> ≤ -0.45),  
 
                             were chosen, rather than designs that included several mutations,  
 
                             were chosen, rather than designs that included several mutations,  
 
                             computed together and could include one or more non ‘Potentially Stabilizing’ mutations, but with a total ΔΔG<sub>calc</sub> ≤ -0.45.
 
                             computed together and could include one or more non ‘Potentially Stabilizing’ mutations, but with a total ΔΔG<sub>calc</sub> ≤ -0.45.
Line 118: Line 113:
 
                                     <img src='https://static.igem.org/mediawiki/2016/9/9e/A249PBGU.png' class="designPics">
 
                                     <img src='https://static.igem.org/mediawiki/2016/9/9e/A249PBGU.png' class="designPics">
 
                                     <figcaption>
 
                                     <figcaption>
−
                                         A249P - Proline adds to the rigidity of the protein structure.
+
                                         A249P - Proline (shown in yellow) is added to increase the rigidity of the protein structure.
 
                                     </figcaption>
 
                                     </figcaption>
 
                                 </figure>
 
                                 </figure>
Line 127: Line 122:
 
                                     <figcaption>
 
                                     <figcaption>
 
                                         M259F - A ‘hole’ inside the protein core could be destabilizing to the protein structure.
 
                                         M259F - A ‘hole’ inside the protein core could be destabilizing to the protein structure.
−
                                         Phenylalanine with a benzyl side group (hydrophobic) is used to ‘fill’ the hole, thus making the protein more stable.
+
                                         Phenylalanine (shown in yellow) with a benzyl side group (hydrophobic) is used to ‘fill’ the hole, thus making the protein more stable.
 
                                     </figcaption>
 
                                     </figcaption>
 
                                 </figure>
 
                                 </figure>
Line 141: Line 136:
 
                             </div>
 
                             </div>
 
                         </div>
 
                         </div>
 +
                        <p>
 +
                            <b>Cells, Plasmids and Enzymes</b>
 +
                        </p>
 +
                        <p>
 +
                            <i>E. coli</i> strain MG1655 was used for cloning of the LC-Cutinase genes into the pACYC vector backbone. <i>E. coli</i> strain BL21 was used for protein expression.
 +
                            The wild type LC-Cutinase gene with the pelB leader sequence was obtained from the <a href='https://2012.igem.org/Team:UC_Davis'>UC-Davis 2012 iGEM team</a> (<a href='http://partsregistry.org/wiki/index.php?title=Part:BBa_K936013'>Part:BBa_K936013</a>) and was amplified using primers containing restriction sites that match the pACYC backbone.
 +
                            The amplified gene was restricted with XhoI and BglII and ligated into pACYC using the T4 ligase enzyme.
 +
                        </p>
 +
                        <p>
 +
                            After validating positive clones, activity tests were performed using a pNP-butyrate assay and PET degradation assays.
 +
                        </p>
 +
                        <img src="https://static.igem.org/mediawiki/2016/2/2b/Cuti_designBGU.png" alt="" class="designPics">
 +
                       
 
                     </div>
 
                     </div>
 
                 </div>
 
                 </div>
Line 155: Line 163:
 
                             <i>Pseudomonas putida</i> bacterium. Two vectors for cloning were chosen and ordered from the Standard European Vector  
 
                             <i>Pseudomonas putida</i> bacterium. Two vectors for cloning were chosen and ordered from the Standard European Vector  
 
                             Architecture’s (SEVA) collection. The 2 vectors chosen are pSEVA224 and pSEVA434. We have chosen the pSEVA plasmids because
 
                             Architecture’s (SEVA) collection. The 2 vectors chosen are pSEVA224 and pSEVA434. We have chosen the pSEVA plasmids because
−
                             they have been previously used in the <i>P. putida</i> KT2440 strain by the D. Taufik group from the Weizman Institute, who
+
                             they have been previously used in the <i>P. putida</i> KT2440 strain by the laboratory of Prof. D. Taufik at the Weizmann Institute.
−
                            we acquired the bacteria from.
+
 
                         </p>
 
                         </p>
 
                         <p>
 
                         <p>
Line 173: Line 180:
 
                         </ol>
 
                         </ol>
 
                         <p>
 
                         <p>
−
                             The genes involved in the Terephthalate degradation pathway and transporter were acquired from the 2012 Darmstadt iGEM team
+
                             The genes involved in the Terephthalate degradation pathway and transporter were acquired from the Darmstadt iGEM team, 2012.
 
                             (<a href="https://2012.igem.org/Team:TU_Darmstadt">Link</a>).  
 
                             (<a href="https://2012.igem.org/Team:TU_Darmstadt">Link</a>).  
 
                         </p>
 
                         </p>
 
                         <p>
 
                         <p>
−
                             Prior to each gene, we added the broad-host G10L ribosome binding site, derived from bacteriophage T7 for increased expression.  
+
                             Proximal to each gene, we added the broad-host G10L ribosome binding site, derived from bacteriophage T7 to increase expression.  
−
                             To provide us with an option to excise a specific sequence from the designed insert if needed,  
+
                             To provide us with a versatile vector, that will allow excision of a specific sequence from the designed insert if needed,  
−
                             we designed a restriction cut site between every element (gene or RBS).  
+
                             we added a restriction site between each element (gene or RBS).  
−
                             The cut site had to be unique to avoid cutting the genes or the vector backbone.
+
                             The restriction site had to be unique to avoid digestion of the genes or the vector backbone.
 
                         </p>
 
                         </p>
 
                         <p>
 
                         <p>
−
                             Flanking each insert were sequences homologous to the desired target vector (224 or 434) for cloning using the NEBuilder® HiFi  
+
                             Flanking each insert we designed and added homologous sequences to the desired target vector (224 or 434), for cloning with the NEBuilder® HiFi  
−
                             DNA Assembly Cloning Kit. Furthermore, to provide an alternative cloning strategy, the flanking sequences contained restriction  
+
                             DNA Assembly Cloning Kit. Furthermore, we designed an alternative cloning strategy - using restriction and ligation. The flanking sequences also contained restriction sites for cloning into the multiple cloning site(MCS) of each vector.
−
                            cut sites for cloning into the MCS using restriction digest and ligation.
+
 
                         </p>
 
                         </p>
 
                         <div class="row">
 
                         <div class="row">
 
                             <div class="col-lg-2"></div>
 
                             <div class="col-lg-2"></div>
 
                             <div class="col-lg-8">
 
                             <div class="col-lg-8">
−
                                 <img src='media/putida_design_ben.png' class="designPics">
+
                                 <img src='https://static.igem.org/mediawiki/2016/6/62/Putida_design_benBGU.png' class="designPics">
 
                             </div>
 
                             </div>
 
                         </div>
 
                         </div>
 
                         <p>
 
                         <p>
 
                             Our design for efficient degradation of PET required the symbiosis our our two chosen bacteria - <i>E. coli</i> and
 
                             Our design for efficient degradation of PET required the symbiosis our our two chosen bacteria - <i>E. coli</i> and
−
                             <i>P. putida</i>, so we had devised an apparatus to enable their mutual growth without contact.  
+
                             <i>P. putida</i>, so we devised an apparatus to enable their mutual growth without contact.  
−
                             Our chosen approach utilized a dialysis membrane with a cut-off of 12-14kDa (lower then LC-Cutinase's molecular mass)
+
                             Our chosen approach utilized a dialysis membrane with a cut-off of 12-14kDa, which is lower than LC-Cutinase's molecular mass,
 
                             to enable the diffusion of the PET degradation products outside the bag for utilization by <i>P. putida</i>, while enabling
 
                             to enable the diffusion of the PET degradation products outside the bag for utilization by <i>P. putida</i>, while enabling
 
                             a large concentration of LC-Cutinase inside the bag for efficient degradation of PET.
 
                             a large concentration of LC-Cutinase inside the bag for efficient degradation of PET.
Line 204: Line 210:
 
                             <div class="col-lg-2"></div>
 
                             <div class="col-lg-2"></div>
 
                             <div class="col-lg-8">
 
                             <div class="col-lg-8">
−
                                 <img src='https://static.igem.org/mediawiki/2016/8/87/Dialysis_colorBGU.png' class="designPics">
+
                                 <img src='https://static.igem.org/mediawiki/2016/b/b2/Putida_dia_color_tags.png' class="designPics">
 
                             </div>
 
                             </div>
 
                         </div>
 
                         </div>
Line 227: Line 233:
 
                         </p>
 
                         </p>
 
                         <p>
 
                         <p>
−
                             At first we examined the possibility of adding an electron carrier to the fuel cell,  
+
                             At first, we examined the possibility of adding an electron carrier to the fuel cell,  
 
                             as it was shown to be effective in enhancing the MFCs performance and was demonstrated using this species. We decided to use
 
                             as it was shown to be effective in enhancing the MFCs performance and was demonstrated using this species. We decided to use
−
                             protocatechuic acid as it takes part in the terephthalate metabolic pathway, enabling us to reduce the use of external
+
                             protocatechuic acid as it is part of the terephthalate metabolic pathway, which enables us to reduce the use of external
 
                             reagents and to create a self-sustaining system. Protocatechuic acid had to meet four criteria:  
 
                             reagents and to create a self-sustaining system. Protocatechuic acid had to meet four criteria:  
 
                         </p>
 
                         </p>

Latest revision as of 14:40, 19 October 2016

PlastiCure

Design

Rational Mutagenesis

Protein Mutagenesis

Based on the structure of LC-Cutinase, we decided to use a rational mutagenesis approach, in which we introduce various mutations to the enzyme's sequence. The mutations were designed using the PROSS (Protein Repair One Stop Shop) algorithm, developed by the Fleishman Lab from the Weizmann Institute (Goldenzweig et al 2016).

The algorithm uses the following steps in selecting the mutations:

A sequence alignment was generated between the target wild-type sequence and other homologous sequences, from which several mutations were chosen.

Each mutant’s structure was compared to the wild-type structure, and the energy difference between them was calculated (ΔΔGcalc).

By computing the effects of each mutation separately, rather than in combination with others, design choices which included several ‘Potentially Stabilizing’ mutations (‘Potentially Stabilizing’ are mutations with ΔΔGcalc ≤ -0.45), were chosen, rather than designs that included several mutations, computed together and could include one or more non ‘Potentially Stabilizing’ mutations, but with a total ΔΔGcalc ≤ -0.45.

Here are a few examples of mutations present in our mutated variants:

A249P - Proline (shown in yellow) is added to increase the rigidity of the protein structure.
M259F - A ‘hole’ inside the protein core could be destabilizing to the protein structure. Phenylalanine (shown in yellow) with a benzyl side group (hydrophobic) is used to ‘fill’ the hole, thus making the protein more stable.
S257A - Polar side groups, such as a hydroxyl in Serine, with no hydrogen bonds, are destabilizing as the protein core should be hydrophobic. A mutation changing Serine to Alanine should increase stability.

Cells, Plasmids and Enzymes

E. coli strain MG1655 was used for cloning of the LC-Cutinase genes into the pACYC vector backbone. E. coli strain BL21 was used for protein expression. The wild type LC-Cutinase gene with the pelB leader sequence was obtained from the UC-Davis 2012 iGEM team (Part:BBa_K936013) and was amplified using primers containing restriction sites that match the pACYC backbone. The amplified gene was restricted with XhoI and BglII and ligated into pACYC using the T4 ligase enzyme.

After validating positive clones, activity tests were performed using a pNP-butyrate assay and PET degradation assays.

Metabolic Pathway Engineering

Two inserts were designed to transform the genes necessary for the terephthalate metabolic pathway to the Pseudomonas putida bacterium. Two vectors for cloning were chosen and ordered from the Standard European Vector Architecture’s (SEVA) collection. The 2 vectors chosen are pSEVA224 and pSEVA434. We have chosen the pSEVA plasmids because they have been previously used in the P. putida KT2440 strain by the laboratory of Prof. D. Taufik at the Weizmann Institute.

Two inserts were designed –

  1. Containing 4 genes from the same strain of C. testosteroni for the degradation of Terephthalic acid to Protocatechuic acid – tphA1, tphA2, tphA3, tphB.
  2. Containing 3 genes from C. testosteroni strain KF-1 for the transport of Terephthalic acid from the periplasmic space into the cytoplasm – tphC, tctA, tctB.

The genes involved in the Terephthalate degradation pathway and transporter were acquired from the Darmstadt iGEM team, 2012. (Link).

Proximal to each gene, we added the broad-host G10L ribosome binding site, derived from bacteriophage T7 to increase expression. To provide us with a versatile vector, that will allow excision of a specific sequence from the designed insert if needed, we added a restriction site between each element (gene or RBS). The restriction site had to be unique to avoid digestion of the genes or the vector backbone.

Flanking each insert we designed and added homologous sequences to the desired target vector (224 or 434), for cloning with the NEBuilder® HiFi DNA Assembly Cloning Kit. Furthermore, we designed an alternative cloning strategy - using restriction and ligation. The flanking sequences also contained restriction sites for cloning into the multiple cloning site(MCS) of each vector.

Our design for efficient degradation of PET required the symbiosis our our two chosen bacteria - E. coli and P. putida, so we devised an apparatus to enable their mutual growth without contact. Our chosen approach utilized a dialysis membrane with a cut-off of 12-14kDa, which is lower than LC-Cutinase's molecular mass, to enable the diffusion of the PET degradation products outside the bag for utilization by P. putida, while enabling a large concentration of LC-Cutinase inside the bag for efficient degradation of PET. Shredded PET was added to the dialysis bag and a magnetic stirrer was used to prevent precipitation.

Microbial Fuel Cell

In order to build a self-sustaining system in which part of the energy from PET could be utilized to make clean energy, we decided to use microbial fuel cells (MFC).

We chose a bacterium that is proven to be electrochemically active (Timur et al 2007). Furthermore, it was essential that the bacterium would be able to form a biofilm over the electrode in attempt to improve the MFCs performance (Nielsen, L. 2012). P. putida KT2440 meets these requirements.

At first, we examined the possibility of adding an electron carrier to the fuel cell, as it was shown to be effective in enhancing the MFCs performance and was demonstrated using this species. We decided to use protocatechuic acid as it is part of the terephthalate metabolic pathway, which enables us to reduce the use of external reagents and to create a self-sustaining system. Protocatechuic acid had to meet four criteria:

  1. The mediator redox couple should have a well-defined stoichiometry.
  2. The mediator should be soluble and stable under the conditions present in the fuel cell.
  3. The mediator’s formal potential should be adequate to the enzyme potential.
  4. It should have a fast heterogeneous electrode exchange with the electrode and a fast homogenous electron exchange with the enzyme redox center or enzyme cofactor (Nuñez, M. 2005).

To examine some of those criteria regarding protocatechuic acid we plan to use cyclic voltammetry.

Address:

Ben-Gurion University of the Negev
Ben Gurion 1, Beer Sheva 8410501, Israel

Mail: igembgu2016@gmail.com

Connect With Us!